Navigation Links
Questions Over Value of Glucose Monitoring for Non-insulin Using Diabetes Patients

A new study published on bmj.com today (Tuesday 26 June) questions the value of blood glucose monitoring among patients with well-controlled, non-insulin dependent (type 2) diabetes.

The research, being presented today at the American Diabetes Association Conference, suggests that current guidelines for self-monitoring among these patients should be reviewed.

Non-insulin dependent (type 2) diabetes usually develops in people over 40, especially when the person is overweight. In most cases, insulin injections are not needed. Instead, a combination of dietary measures, weight reduction, and oral medication controls the condition.

Self monitoring for type 2 diabetes is costly, but many doctors believe that it helps to control blood glucose levels and it is commonly recommended. Although some studies have suggested benefits, evidence of effectiveness is still inconclusive.

So Dr Andrew Farmer and colleagues set out to test whether self-monitoring can improve blood glucose control in non-insulin using patients compared with standard care.

They identified 453 non-insulin using type 2 diabetes patients from 48 general practices.

Patients were randomly assigned to one of three groups. The control group received standard care with three-monthly HbA1c measurements by a health professional (a measure of the amount of glucose attached to red blood cells).

The second group was given a meter with advice to contact their clinician for interpretation of results (less intensive self-monitoring), while the third group was given a meter and trained to interpret the readings and apply the results (more-intensive self monitoring).

At 12 months, there was no difference in HbA1c between the groups. There was also no evidence that intensity of monitoring was related to improvements in glucose control.

This trial provides no convincing evidence of an effect of blood glucose monitoring, with or without instruction, in improving glucose control compared with usual care, say the authors.

Routine self-monitoring of blood glucose for reasonably well-controlled non-insulin treated patients with type 2 diabetes appears to offer, at best, small advantages, is not well accepted, and the cost, effort and time involved in the procedures may be better directed to supporting other health-related behaviours, they add.

They suggest that current guidelines for the use of self-monitoring among these patients should be reviewed.


'"/>




Related medicine news :

1. New Study Questions Cannibalism As A Worldwide Selective Force
2. GAO Investigation Questions Validity of DNA Testing Kits
3. African-Americans Pose Less Questions To Treating Doctors
4. Study Of Twins May Solve Aging Questions
5. Research Questions Use of Sleep Meds for Patients with Apnea
6. A Study Questions the Effectiveness of High Speed Colonoscopies
7. NYC Mayor Raises Questions About Male Circumcision as HIV Prevention Method
8. NASA Gets Ready To Address Tough Questions
9. Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore
10. NASA Gets Ready To Address Tough Questions
11. Questions Over Drugs to Prevent Heart Complications During Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... ... Love is in the air at King Kullen! The local grocer is ... staple for Valentine’s Day is a must-have, and can be picked up with all ... are long-stem roses available, but also other flower bouquets, elegantly wrapped and ready to ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... , ... Stuart Bentkover, MD, FACS is thrilled to announce the ... effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts to ... has been approved by the Food and Drug Administration (FDA) as a safe and ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016 ... addition of the "Global Musculoskeletal Partnering ... company profile to their offering. ... addition of the "Global Musculoskeletal Partnering ... company profile to their offering. ...
(Date:2/5/2016)... Dehaier Medical Systems Ltd. (Nasdaq: ... develops, markets and sells medical devices and wearable ... and international markets, today announced its corporate ... the Company,s resources to develop its mobile health ... focus more on its major businesses. As of ...
(Date:2/5/2016)... Site Profile: --> ... The Speech Recognition People, announced their latest primary healthcare case study ... reduce turnaround times and to save the practice money. ... 2013 Challenge: --> ,- Wirral CCG ,- ... Six doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
Breaking Medicine Technology: